Skip to main content
Skip to main content

AAP Gateway

Advanced Search »

User menu

  • Login
  • AAP Policy
  • Topic/Program Collections
  • Submit Manuscript
  • Alerts
  • Subscribe
  • aap.org

Menu

  • AAP Grand Rounds
  • AAP News
  • Hospital Pediatrics
  • NeoReviews
  • Pediatrics
  • Pediatrics in Review
  • Current AAP Policy
  • Journal CME
  • AAP Career Center
  • Pediatric Collections
  • AAP Journals Catalog

Sections

    • Login
    • AAP Policy
    • Topic/Program Collections
    • Submit Manuscript
    • Alerts
    • Subscribe
    • aap.org

    Sign up for Insight Alerts highlighting editor-chosen studies with the greatest impact on clinical care.
    Video Abstracts -- brief videos summarizing key findings of new articles
     

    Advertising Disclaimer »

    Tools and Links

    Pediatrics
    November 2011, VOLUME 128 / ISSUE Supplement 4
    SUPPLEMENT ARTICLE

    Hospitals and Complementary and Alternative Medicine: Managing Responsibilities, Risk, and Potential Liability

    Joan Gilmour, Christine Harrison, Leyla Asadi, Michael H. Cohen, Sunita Vohra
    • Article
    • Figures & Data
    • Info & Metrics
    • Comments
    Loading
    Download PDF

    Abstract

    Patients and families increasingly press hospitals to facilitate provision of complementary and alternative medicine (CAM) therapies and products. At the same time, a growing number of hospitals and health care facilities have taken steps to integrate CAM and conventional care. In this article we consider institutional responsibilities when patients/parents use or are considering CAM. We (1) review hospitals' responsibilities to patients and parents, (2) explain how these principles apply in the case of CAM practitioners and products, (3) address institutional responsibilities for different models of service delivery, and (4) highlight issues that should be addressed when developing institutional policies to govern CAM use and propose ways to do so.

    • complementary therapies
    • hospitals
    • policy-making
    • organization policy

    We continue with the example of 6-year-old Jake's success with acupuncture for chemotherapy-induced nausea and vomiting, described in the preceding article in this supplemental issue of Pediatrics.1His parents had originally requested that he receive acupuncture at the local children's hospital where he was an inpatient. The hospital concluded that its policies did not allow for a community-based acupuncturist to deliver inpatient care. When Jake's parents took him out of the hospital on intermittent passes for acupuncture treatments, the frequency and severity of his adverse effects decreased, and he began eating better and regaining weight. His parents are delighted but remain distressed that they were unable to obtain inpatient acupuncture therapy or coordinate care between his oncologist and acupuncturist. They wonder whether arrangements could be made to better integrate conventional treatment and complementary and alternative medicine (CAM) therapies.

    In this article we consider institutional responsibilities when patients use CAM. Patients and families increasingly press hospitals to facilitate provision of CAM therapies and products. At the same time, a growing number of hospitals and other health care facilities have taken steps to integrate conventional and CAM care2,–,5; some of them have adopted formal policies, whereas others proceed on a more informal, ad hoc basis.6,–,9

    Here, we (1) review hospitals' responsibilities to patients/parents, (2) explain how these principles apply in the case of CAM practitioners and products, (3) explore the implications of different models of service delivery for hospitals, and (4) highlight issues that should be addressed when developing institutional policies to govern CAM.

    ETHICS: ORGANIZATIONAL RESPONSIBILITY AND FAMILY-CENTERED CARE

    Organizational ethics in health care comprises issues with which a health care organization must grapple to ensure that care is provided in a safe, efficient, and respectful way, consistent with its mission.10,11

    Health care organizations that care for children often profess to offer family-centered care.12 Beyond the recognition that children are a part of families and families are deeply involved and invested in their child's treatment, family-centered care suggests that a family's values and beliefs shape not only their decisions and perceptions of what is in their child's best interests but also their understanding of and the meaning they assign to health and illness. Folk remedies, traditional medicines, and healers are important and meaningful to many cultures and, indeed, are used by most of the world's population as first-line therapy. Because many families incorporate CAM into their health strategies, hospitals should recognize this fact and, when possible, accommodate reasonable requests from families who wish to receive natural health products or CAM services within the hospital setting. Of course, hospitals have a duty to create a safe environment for patients, which should include going to reasonable lengths to provide or allow provision of safe and effective CAM treatments that current evidence indicates could improve patients' health or help them manage their symptoms.

    Although hospital administrators have obligations that extend beyond those to particular patients and families, they should enable the provision of care that is consistent with patient and family preferences and values when it is also consistent with providing a safe environment and meeting their fiscal responsibilities.

    LAW

    Even in different jurisdictions, hospitals share broad areas of legal responsibility. Hospitals owe a legal duty to provide reasonable care for patients.13 A hospital may be directly liable to a patient for its own negligence or breach of contract when it fails to meet its obligations.13,14 It may also be vicariously liable for the negligence of those for whom it is legally responsible, such as employees and those with apparent authority to act on its behalf.13,14 If a hospital decides to allow CAM practitioners to provide care on-site or to coordinate care with CAM practitioners off-site, it must be cognizant of both its duty of care to patients and that owed by service providers. General legal principles governing hospital liability provide the starting point for analysis.

    Direct Liability

    In the United States and Canada, the most common duties hospitals owe patients are “(1) to use reasonable care in the maintenance of safe and adequate facilities and equipment; (2) … to select and retain only competent physicians; (3) … to oversee all persons who practice medicine within its walls as to patient care; and (4) … to formulate, adopt and enforce adequate rules and policies to ensure quality care for the patients.”14(p474),15,* Legal scholars in Canada and the United States identify the most basic duty of the hospital as ensuring that those who treat patients are qualified and competent.13,14 This obligation is not limited to hospital employees; it extends to physicians and other health professionals such as midwives and dentists who are granted privileges to work in the hospital but are not employed by it. The hospital has to ensure that personnel are working within their competence and receive appropriate training and supervision. Hospitals must also establish “safe systems” for the protection of patients16,17 and ensure proper coordination among the various elements of patients' treatment programs.13,17,–,19

    Vicarious Liability

    In addition to direct liability for their own failure to take reasonable care, hospitals can be held vicariously liable for the negligence of those for whom they are legally responsible, such as employees and volunteers, provided they are acting within the scope of their employment or duties.16,20,–,22 In Canada, hospitals are generally not liable for the negligence of nonemployees, which is the position of most physicians and others, such as dentists, who have been granted privileges to work at the hospital and may be affiliated as independent practitioners.16 However, recent developments in the law may make this limit on hospitals' liability vulnerable to challenge.13,20,23 Courts in the United States have been more willing to hold hospitals liable for nonemployed physicians' negligence and have most often used theories of ostensible agency, apparent authority, or nondelegable duty.24,–,26

    Managing Risk Associated With CAM Therapies for Acupuncture

    Lawsuits alleging that CAM use caused harm are rare,27,28 and allegations of institutional responsibility are more rare still. In 1 Canadian case, a negligence claim against an acupuncturist and a physician-owner of the clinic at which treatment was received was settled before trial.29 Whether a hospital would be liable if a CAM practitioner negligently injured a patient would depend on the relationships between the hospital, the patient/parents, and the CAM practitioner and the circumstances and terms under which treatment was provided. Different arrangements may prevail. The most common arrangements are listed in Table 1.

    View this table:
    • View inline
    • View popup
    TABLE 1

    Potential Hospital Liability for Negligence of CAM Providers

    Because adequate supervision and control offer the best opportunity to prevent or limit substandard care and patient injury, the wisest course for hospitals that allow on-site provision of CAM is to take reasonable steps to control and supervise practitioners to maintain safety and quality of care.26

    Managing Risk Associated With CAM Products

    CAM products can present different challenges, especially because patients often use natural health products or dietary supplements without consulting health care providers. If the prospect of toxicity or adverse interactions between conventional treatments and pharmaceuticals and CAM therapies or products is known or ought to be known and is not effectively managed, resulting in harm to patients, both clinicians and their hospital could face the prospect of liability.30,31

    CLINICAL RESPONSE

    Despite success in extending survival rates for pediatric cancer (in 2000, >70% of children who developed cancer were expected to survive32), chemotherapy-induced nausea and vomiting remain significant and debilitating adverse effects. CAM use is prevalent in pediatric oncology33,–,35; utilization rates are estimated in the range of 36% to 46%. Of 17 academic pediatric integrative medicine programs in North America, 8 offer integrative cancer care or access to acupuncture.9

    Parents rarely believe that CAM will cure their child's cancer. Instead, they use CAM in conjunction with conventional therapy to provide relaxation and comfort and improve overall health.36,37 In pediatric oncology, “lack of confidence” or “disappointment” in conventional treatment is rarely cited as a factor when seeking CAM therapies. Instead, parents' decision to turn to CAM is based on their desire to do “everything possible.”34,38 Accustomed to being their child's substitute decision-makers, parents want to work closely and collaboratively with health care providers.34 Integrating CAM therapies that offer a reasonable prospect of therapeutic benefit is a way to assure parents that hospitals and clinics will aid them in doing everything possible to make their child as comfortable as possible. Nevertheless, integration is not simple; it depends, in part, on the level of staff expertise and comfort with CAM and whether there are institutional barriers, including perceptions of CAM and concerns about potential liability.39

    Medical leadership should initiate the development of guidelines and policies to respond to requests for CAM and perhaps establish a multidisciplinary working group with family representation. Less may be known about particular types of CAM than conventional health care, but decision-making under conditions of uncertainty occurs frequently in conventional health care as well. An important starting point would be to assess anticipated benefits and risks of the treatment on the basis of available evidence of safety and efficacy. Adams et al40 proposed a decision-making framework to assist clinicians' assessment of CAM therapies and suggested that (1) if evidence supports both safety and efficacy, the physician should recommend the therapy but continue to monitor conventionally, (2) if evidence supports safety but is inconclusive about efficacy, then the treatment should be cautiously tolerated and monitored for efficacy, and (3) if evidence supports efficacy but is inconclusive about safety, the therapy could be tolerated and monitored closely for safety. However, (4) if evidence indicates either serious risk or inefficacy, the treatments should be avoided and patients actively discouraged from use.40,41 This framework could be adapted to hospital decision-making but with the caveats we noted earlier in this series42: evidence for many types of CAM therapies is lacking,40 CAM therapies must still be assessed in light of conventional therapies and what they offer patients, and there is a special duty to act in the best interests of those pediatric patients who are not yet capable of making their own treatment decisions.

    It would be prudent for hospitals and other health facilities to consider adopting a formal protocol and/or some formal process to establish (1) what CAM therapies to allow or make available on-site, (2) which kinds of CAM practitioners can provide them, (3) under what conditions would they provide them, and (4) how the practitioners will function and interact with patients, other health care providers, and the institution.27,43,44

    RECOMMENDATIONS FOR INSTITUTIONAL POLICY DEVELOPMENT

    The following are issues that should be considered when formulating policy.

    Credentialing

    Credentialing is “the process of obtaining, verifying, and assessing the qualifications of a health care practitioner to provide patient care services in or for a health care organization.”45 Hospitals could adapt credentialing processes used for other health care providers to CAM practitioners,43,46 which would include proof of licensure or membership in a regulated health profession (when applicable); satisfactory completion of required courses, examinations, and continuing education; satisfactory history in relation to disciplinary action and malpractice liability; and, for nonemployees, appropriate malpractice insurance. If the practitioner is not a member of a health profession regulated by statute, then consideration should be given to specifying required training and completion of examinations or certification by an authoritative body.47

    Even if CAM practitioners are not credentialed by the hospital and their provision of services at the patients' or families' request is merely accepted, the hospital should still ascertain the practitioner's identity and training and what care will be provided on-site so that it can fulfill its obligation to provide a safe environment for its patients.

    As with conventional health care, additional controls are needed to ensure practitioner competence and that treatments meet hospital requirements for safety and efficacy, as outlined in the following section.

    Governing CAM Practice

    Informed Consent

    It is essential to obtain informed consent for treatment regardless of whether it is conventional care or CAM.1 Given the nature of the treatment, the hospital may wish to specify what information must be reviewed with patients/parents (eg, the nature and strength of evidence supporting the therapy and the potential for interactions between CAM and conventional therapies such as adverse herb–drug interactions).

    Standard of Care

    CAM is an emerging area for practice, regulation, and research; as such, the evidence base is generally less developed than for much conventional health care.26,48 This lack of evidence can make the task of developing institutional standards of practice difficult, particularly for unregulated practitioners. However, research is ongoing, and information about safety and efficacy is increasing and should enable more informed judgments to be made. Hospitals will have to determine how they will weigh risks and benefits and what level or kind of evidence of safety and efficacy will be sufficient to allow therapeutic recommendations.49 The decision-making framework described previously could provide a useful starting point for this process.

    If a CAM therapy is recommended or undertaken, provision should be made for how, by whom, and where the rationale for this therapeutic choice, patient/parent consent, and the care provided will be documented.50

    Scope of Practice

    Hospitals should be aware of the scope of CAM providers' practice authorized by legislation and ensure that therapies provided on-site comply with regulatory requirements. Uncertainty about safety or efficacy may affect decisions about the scope of practice permitted on-site. Institutions may narrow CAM providers' scope of practice in the hospital from that authorized by their governing statute. If there is not convincing evidence of efficacy for some part of CAM providers' practices, some American health care institutions limit them to what is supported in the literature.43 Alternatively, institutions may limit provision of some treatments to specified types of practitioners such as members of regulated professions.39

    Collaborative Practice

    Hospitals should develop protocols to guide collaborative practice among different types of practitioners (conventional or CAM) and clarify their respective roles and responsibilities.26,51

    Supervision

    Liability implications for supervisors and the institution should be assessed, particularly if the supervisor is an independent practitioner and not a hospital employee.

    Duty to Refer

    Consideration should be given to outlining circumstances in which CAM providers should refer for conventional care. Conversely, there may be instances when conventional providers should consider referral to CAM providers, depending on the strength of evidence for a particular application. Policies should be consistent with regulatory requirements, such as a duty to refer to a physician if there has been no improvement within a specified time.52,–,54

    Monitoring

    Patients should be monitored by conventional means and conventional care should be provided as appropriate, with consent. In hospitals, CAM is generally meant to be a complement to conventional care, not a replacement or substitute. Health care providers need to be alert to the possibility that CAM may affect the therapeutic benefits that conventional care can provide, whether synergistically or antagonistically.30,55

    Products

    The prevalence of patient-initiated use of CAM products without consultation suggests the need to (1) ascertain and document patient use, (2) consider what products can be used while the patient is in the hospital and which must be discontinued, (3) clearly explain these policies to patients, and (4) monitor compliance to avoid risk to patients' health.56

    Quality Assurance

    Hospitals have important responsibilities to ensure the quality of care. Obligations to report adverse events internally and externally and to disclose harm to patients are expanding.23,57,58 Quality-assurance programs can and should be adapted and applied to CAM.

    Liability Insurance

    When employees provide CAM, hospitals need to ensure that existing liability insurance covers this type of care.

    For CAM providers who are independent practitioners, consideration should be given to whether the practitioner must establish proof of adequate insurance coverage. Practices applicable to other nonemployees who are credentialed and have hands-on responsibilities for patient care could provide useful guidance about both insurance and indemnification.

    Cost

    Hospitals, patients/parents, and practitioners need a clear understanding of who is responsible for payment. Private third-party insurance may not cover CAM services or may limit reimbursement. Coverage under public health insurance plans for CAM treatments in Canada is limited or nonexistent.59,60

    ACKNOWLEDGMENTS

    Funding for this project was partially provided by the SickKids Foundation (Toronto, Ontario, Canada). Dr Vohra received salary support from the Alberta Heritage Foundation for Medical Research and the Canadian Institutes of Health Research.

    We gratefully acknowledge the contributions of Soleil Surette and Alison Henry for help in literature searching and manuscript preparation, Maya Goldenberg and Andrew Milroy for bioethics research assistance, and Osgoode Hall Law School students (now graduates) Nicola Simmons, David Vitale, Kristine Bitterman, and Janet Chong for assistance with legal research.

    Footnotes

      • Accepted March 30, 2011.
    • Address correspondence to Sunita Vohra, MD, MSc, Edmonton General Hospital, 8B19-11111 Jasper Ave, Edmonton, Alberta, Canada T5K 0L4. E-mail: svohra{at}ualberta.ca
    • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

    • ↵* These duties are phrased similarly in Canada: “1. to select competent staff and monitor their continued competence; 2. to provide proper instruction and supervision; 3. to provide proper facilities and equipment; and 4. to establish systems necessary for the safe operation of the hospital.”13(p460)

    • CAM —
      complementary and alternative medicine

    REFERENCES

    1. 1.↵
      1. Gilmour J,
      2. Harrison C,
      3. Asadi L,
      4. Cohen MH,
      5. Vohra S
      . Informed consent: advising patients and parents about complementary and alternative medicine therapies. Pediatrics. 2011;128(5 pt 4):S187–S192
      OpenUrlAbstract/FREE Full Text
    2. 2.↵
      Consortium of Academic Health Centers for Integrative Medicine. Members. Available at: www.imconsortium.org/members/home.html. Accessed August 18, 2010
    3. 3.↵
      1. Cohen M,
      2. Sandler L,
      3. Hrbek A,
      4. Davis R,
      5. Eisenberg D
      . Policies pertaining to complementary and alternative medical therapies in a random sample of 39 academic health centers. Altern Ther Health Med. 2005;11(1):36–40
      OpenUrlPubMed
    4. 4.↵
      1. Lin YC,
      2. Lee AC,
      3. Kemper KJ,
      4. Berde CB
      . Use of complementary and alternative medicine in pediatric pain management service: a survey. Pain Med. 2005;6(6):452–458
      OpenUrlCrossRefPubMedWeb of Science
    5. 5.↵
      1. Highfield ES,
      2. Kaptchuk TJ,
      3. Ott MJ,
      4. Barnes L,
      5. Kemper KJ
      . Availability of acupuncture in the hospitals of a major academic medical center: a pilot study. Complement Ther Med. 2003;11(3):177–1836
      OpenUrlCrossRefPubMedWeb of Science
    6. 6.↵
      1. Gardiner P,
      2. Phillips RS,
      3. Kemper KJ,
      4. Legedza A,
      5. Henlon S,
      6. Woolf AD
      . Dietary supplements: inpatient policies in US children's hospitals. Pediatrics. 2008;121(4). Available at: www.pediatrics.org/cgi/content/full/121/4/e775
    7. 7.↵
      Joint Commission on Accreditation of Healthcare Organizations. In: Comprehensive Accreditation Manual for Hospitals (CAMH). Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 2004:mm1–mm20
    8. 8.↵
      American Society of Health-System Pharmacists. ASHP statement on the use of dietary supplements. Available at: www.ashp.org/DocLibrary/BestPractices/SpecificStDietSuppl.aspx. Accessed March 1, 2011
    9. 9.↵
      1. Vohra S,
      2. Mittra D,
      3. Kemper K,
      4. Gardiner P,
      5. Rosen L
      . Pediatric integrative medicine: pediatrics newest subspecialty? North American Research Conference on Complementary and Integrative Medicine. Altern Ther Health Med. 2009;15(3):s158
      OpenUrl
    10. 10.↵
      1. Reiser SJ
      . The ethical life of health care organizations. Hastings Cent Rep. 1994;24(6):28–35
      OpenUrlPubMedWeb of Science
    11. 11.↵
      1. Iltis AS
      . Values based decision making: organizational mission and integrity. HEC Forum. 2005;17(1):6–17
      OpenUrlCrossRefPubMed
    12. 12.↵
      1. Rauch Percelay JM,
      2. Zipes D
      . Introduction to pediatric hospital medicine. Pediatr Clin North Am. 2005;52(4):963–977
      OpenUrlCrossRefPubMedWeb of Science
    13. 13.↵
      1. Picard E,
      2. Robertson G
      . Legal Liability of Doctors and Hospitals in Canada. 4th ed. Toronto, Ontario, Canada: Carswell; 2007:460
    14. 14.↵
      1. Furrow B,
      2. Greaney T,
      3. Johnson S,
      4. Jost T,
      5. Schwartz R
      . Health Law. 6th ed. St Paul MN: Thomson West; 2008:474–475
    15. 15.
      Thompson v Nason Hospital (1991), 591 A 2d 703 (Pa).
    16. 16.↵
      Yepremian v Scarborough General Hospital (1980), 28 OR (2d) 494 (CA).
    17. 17.↵
      Braun Estate v Vaughan (2000), Man J No. 63 (CA), paras 45, 49.
    18. 18.↵
      Lachambre v Nair (1989), 2 WWR 749 (Sask QB) at 768.
    19. 19.↵
      Jennison v Providence St Vincent Medical Center (2001), 25 P 3d 358 (CA Oregon).
    20. 20.↵
      Bazley v Curry (1999), 2 SCR 534.
    21. 21.↵
      Boyd v Albert Einstein Medical Center (1988), 547 A 2d 1229 (Pa Sup Ct).
    22. 22.↵
      1. Cohen M
      . Referrals to complementary and alternative medicine providers. In: Beyond Complementary Medicine: Legal and Ethical Perspectives on Health Care and Human Evolution. Ann Arbor, MI; University of Michigan Press; 2000:65–66
    23. 23.↵
      1. Gilmour J
      . Patient safety, medical error and tort law: an international comparison—final report. Available at: http://osgoode.yorku.ca/osgmedia.nsf/0/094676DE3FAD06A5852572330059253C/$FILE/FinalReport_Full.pdf. Accessed August 18, 2010
    24. 24.↵
      1. Furrow B,
      2. Greaney T,
      3. Johnson S,
      4. Jost T,
      5. Schwartz R
      . Liability of health-care institutions. In: Health Law: Cases, Materials and Problems. 6th ed. St Paul, MN: Thomson/West; 2008:437–559
    25. 25.↵
      Burless v West Virginia University Hospitals Inc (2004), 601 SE 2d 85 (WVa SC).
    26. 26.↵
      1. Faass N
      1. Cohen M
      . Malpractice in complementary and alternative medicine: practical implications for risk managers. In: Faass N eds. Integrating Complementary Medicine Into Health Systems. Gaithersburg, MD: Aspen; 2001:226–234
    27. 27.↵
      1. Studdert DM,
      2. Eisenberg DM,
      3. Miller FH,
      4. Curto DA,
      5. Kaptchuk TJ,
      6. Brennan TA
      . Medical malpractice implications of alternative medicine. JAMA. 1998;280(18):1610–1615
      OpenUrlCrossRefPubMedWeb of Science
    28. 28.↵
      1. Crouch R,
      2. Elliott R,
      3. Lemmens T,
      4. Charland L
      . Complementary/Alternative Health Care and HIV/AIDS: Legal, Ethical and Policy Issues in Regulation. Toronto, Ontario, Canada: Canadian HIV/AIDS Legal Network; 2001
    29. 29.↵
      Rose v Pettle (2004), OJ No. 739 (SC), (2006), OJ No. 1612 (SC).
    30. 30.↵
      1. Gilmour J,
      2. Harrison C,
      3. Asadi L,
      4. Cohen MH,
      5. Vohra S
      . Natural health product–drug interactions: evolving responsibilities to take complementary and alternative medicine into account. Pediatrics. 2011;128(5 pt 4):S155–S160
      OpenUrlAbstract/FREE Full Text
    31. 31.↵
      1. Cohen M,
      2. Hrbek A,
      3. Davis R,
      4. Schachter S,
      5. Eisenberg D
      . Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations. Arch Intern Med. 2005;165(3):289–295
      OpenUrlCrossRefPubMedWeb of Science
    32. 32.↵
      1. Rudolph CD,
      2. Rudolph AM
      eds. Rudolph's Pediatrics. 21st ed. New York, NY: McGraw-Hill; 2003
    33. 33.↵
      1. Bold J,
      2. Leis A
      . Unconventional therapy use among children with cancer in Saskatchewan. J Pediatr Oncol Nurs. 2001;18(1):16–25
      OpenUrlAbstract/FREE Full Text
    34. 34.↵
      1. Fernandez CV,
      2. Stutzer CA,
      3. MacWilliam L,
      4. Fryer C
      . Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol. 1998;16(4):1279–1286
      OpenUrlAbstract/FREE Full Text
    35. 35.↵
      1. Martel D,
      2. Bussieres JF,
      3. Theoret Y,
      4. et al
      . Use of alternative and complementary therapies in children with cancer. Pediatr Blood Cancer. 2005;44(7):660–668
      OpenUrlCrossRefPubMedWeb of Science
    36. 36.↵
      1. Post-White J,
      2. Hawks RG
      . Complementary and alternative medicine in pediatric oncology. Semin Oncol Nurs. 2005;21(2):107–114
      OpenUrlCrossRefPubMed
    37. 37.↵
      1. Kelly KM
      . Complementary and alternative medical therapies for children with cancer. Eur J Cancer. 2004;40(14):2041–2046
      OpenUrlCrossRefPubMedWeb of Science
    38. 38.↵
      1. Grootenhuis MA,
      2. Last BF,
      3. de Graaf-Nijkerk JH,
      4. van der Wel M
      . Use of alternative treatment in pediatric oncology. Cancer Nurs. 1998;21(4):282–288
      OpenUrlCrossRefPubMedWeb of Science
    39. 39.↵
      1. Cohen M,
      2. Ruggie M
      . Integrating complementary and alternative medical therapies in conventional medical settings: legal quandaries and potential policy models. Cincinnatti Law Rev. 2004;72(2):671–729
      OpenUrl
    40. 40.↵
      1. Adams K,
      2. Cohen M,
      3. Eisenberg D
      . Ethical considerations of complementary and alternative medical therapies in conventional medical settings. Ann Intern Med. 2002;137(8):660–664
      OpenUrlPubMedWeb of Science
    41. 41.↵
      1. Cohen M,
      2. Eisenberg D
      . Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann Intern Med. 2002;136(8):596–603
      OpenUrlCrossRefPubMedWeb of Science
    42. 42.↵
      1. Gilmour J,
      2. Harrison C,
      3. Cohen MH,
      4. Vohra S
      . Pediatric use of complementary and alternative medicine: legal, ethical, and clinical issues in decision-making. Pediatrics. 2011;128(5 pt 4):S149–S154
      OpenUrlAbstract/FREE Full Text
    43. 43.↵
      1. Eisenberg D,
      2. Cohen M,
      3. Hrbek A,
      4. Grayzel J,
      5. Van Rompay M,
      6. Cooper R
      . Credentialing complementary and alternative medical providers. Ann Intern Med. 2002;137(12):965–973
      OpenUrlCrossRefPubMedWeb of Science
    44. 44.↵
      1. Smallwood C
      . The Role of Complementary and Alternative Medicine in the NHS: An Investigation Into the Potential Contribution of Mainstream Complementary Therapies to Healthcare in the UK. London, United Kingdom: FreshMinds; 2005
    45. 45.↵
      1. O'Leary MR
      ; Joint Commission on Accreditation of Healthcare Organizations. Lexikon: Dictionary of Health Care Terms, Organizations, and Acronyms. 2nd ed. Oakbrook Terrace, IL: Join Commission; 1998:59
    46. 46.↵
      Hospital Standards Act, R.S.S. 1978, c.H-10, as amended.
    47. 47.↵
      1. Faass N
      1. Ina V
      . Credentialing complementary practitioners. In: Faass N eds. Integrating Complementary Medicine Into Health Systems. Gaithersburg, MD: Aspen; 2001:188–206
    48. 48.↵
      1. Barnes PM,
      2. Bloom B,
      3. Nahin RL
      . Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;(12):1–23. Available at: www.cdc.gov/nchs/data/nhsr/nhsr012.pdf. Accessed August 10, 2010
    49. 49.↵
      Institute of Medicine, Committee on the Use of Complementary and Alternative Medicine. Contemporary approaches to evidence of treatment effectiveness: a context for CAM; Need for innovative designs in research on CAM and conventional medicine; and State of emergency evidence on CAM. In: Complementary and Alternative Medicine in the United States. Washington, DC: National Academies Press; 2005:74–167
    50. 50.↵
      1. Cohen AJ,
      2. Menter A,
      3. Hale L
      . Acupuncture: role in comprehensive cancer care—a primer for the oncologist and review of the literature. Integr Cancer Ther. 2005;4(2):131–143
      OpenUrlAbstract/FREE Full Text
    51. 51.↵
      1. Prada G,
      2. Swettenham J,
      3. Ries N,
      4. Martin J
      . Liability Risks in Interdisciplinary Care: Thinking Outside the Box. Toronto, Ontario, Canada: Conference Board of Canada; 2007. Available at: www.conferenceboard.ca/documents.aspx?did=1979. Accessed August 10, 2010
    52. 52.↵
      Traditional Chinese Medicine and Acupuncturists Regulation, BC Reg 290/2008.
    53. 53.↵
      Acupuncture Regulation, Alta Reg 42/1998, made under the Health Disciplines Act, R.S.A. 2000, c. H-2, Sch. G.
    54. 54.↵
      1. Gilmour J,
      2. Harrison C,
      3. Asadi L,
      4. Cohen MH,
      5. Vohra S
      . Complementary and alternative medicine practitioners' standard of care: responsibilities to patients and parents. Pediatrics. 2011;128(5 pt 4):S200–S205
      OpenUrlAbstract/FREE Full Text
    55. 55.↵
      1. Laeeque H,
      2. Charrois TL,
      3. Vohra S
      . Adverse effects and drug interactions relating to use of St John's wort. Can Pharm J. 2006;139(1):30–33
      OpenUrlFREE Full Text
    56. 56.↵
      1. Tollec S,
      2. Lebel D,
      3. Bussieres JF
      . Are we ready to manage natural health products in hospital practice? Can J Clin Pharmacol. 2010;17(1):e128–e131
      OpenUrl
    57. 57.↵
      1. Kohn L,
      2. Corrigan J,
      3. Donaldson M
      eds. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000
    58. 58.↵
      Darling v Charleston Community Memorial Hospital (1965), 211 NE 2d 253 (Ill SC).
    59. 59.↵
      British Columbia: provincial health plan to cover acupuncture. The Toronto Star. March 31, 2008:A17
    60. 60.↵
      1. Gilmour J,
      2. Kelner M,
      3. Wellman B
      . Opening the door to complementary and alternative medicine: self-regulation in Ontario. Law Policy. 2002;24:149–174
      OpenUrlCrossRef
    • Copyright © 2011 by the American Academy of Pediatrics
    View Abstract
    PreviousNext

     

    Advertising Disclaimer »

    View this article with LENS
    PreviousNext
    Email

    Thank you for your interest in spreading the word on Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Hospitals and Complementary and Alternative Medicine: Managing Responsibilities, Risk, and Potential Liability
    (Your Name) has sent you a message from Pediatrics
    (Your Name) thought you would like to see the Pediatrics web site.

    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Hospitals and Complementary and Alternative Medicine: Managing Responsibilities, Risk, and Potential Liability
    Joan Gilmour, Christine Harrison, Leyla Asadi, Michael H. Cohen, Sunita Vohra
    Pediatrics Nov 2011, 128 (Supplement 4) S193-S199; DOI: 10.1542/peds.2010-2720I

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Hospitals and Complementary and Alternative Medicine: Managing Responsibilities, Risk, and Potential Liability
    Joan Gilmour, Christine Harrison, Leyla Asadi, Michael H. Cohen, Sunita Vohra
    Pediatrics Nov 2011, 128 (Supplement 4) S193-S199; DOI: 10.1542/peds.2010-2720I
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Print
    PDF
    Insight Alerts
    • Table of Contents
    • Current Policy
    • Early Release
    • Current Issue
    • Past Issues
    • Editorial Board
    • Editorial Policies
    • Overview
    • Features Video
    • Open Access
    • Pediatric Collections
    • Video Abstracts
    • Author Guidelines
    • Reviewer Guidelines
    • Submit My Manuscript

    Subjects

    • Pharmacology
      • Therapeutics
      • Pharmacology
    Back to top

                

    Copyright © 2019 by American Academy of Pediatrics

    International Access »

    Terms of Use
    The American Academy of Pediatrics (AAP) takes the issue of privacy very seriously. See our Privacy Statement for information about how AAP collects, uses, safeguards and discloses the information collected on our Website from visitors and by means of technology.
    FAQ

     

    AAP Pediatrics